Literature DB >> 15650076

Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin.

Tadashi Morimura1, Katsuhiko Tsunekawa, Takayuki Kasahara, Koji Seki, Takayuki Ogiwara, Masatomo Mori, Masami Murakami.   

Abstract

Thyroid hormones play important roles in bone growth, development, and turnover. To exert its biological activity, T(4) needs to be converted to T(3) by iodothyronine deiodinase. In human thyroid gland as well as rat brown adipose tissue, type 2 iodothyronine deiodinase (D2) expression is regulated by a TSH receptor-cAMP-mediated mechanism. TSH receptor knockout mice demonstrated the direct effects of TSH on bone via TSH receptors found on osteoblast and osteoclast precursors. In the present study we investigated the possible expression and function of iodothyronine deiodinase and TSH receptors in human osteoblast-like osteosarcoma (SaOS-2) cells and normal human osteoblast (NHOst) cells. Iodothyronine deiodinase activity was detected in SaOS-2 cells and NHOst cells, and all of the characteristics of deiodinating activity were compatible with those of D2. Northern analysis demonstrated D2 mRNA expression in SaOS-2 cells and NHOst cells. D2 mRNA levels as well as D2 activities were rapidly increased by dibutyryl cAMP or forskolin in SaOS-2 cells and NHOst cells. TSH receptor mRNA was demonstrated in SaOS-2 cells and NHOst cells, and D2 mRNA and D2 activity were stimulated by TSH in both cells. In addition, all T(3) receptor isoforms were detected by RT-PCR in SaOS-2 cells and NHOst cells. The present results indicate the expression of functional TSH receptors and D2 in human osteoblasts and suggest previously unrecognized roles of TSH receptors and local T(3) production by D2 in the pathophysiology of human osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650076     DOI: 10.1210/en.2004-1432

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  The genetics of the thyroid stimulating hormone receptor: history and relevance.

Authors:  Terry F Davies; Xiaoming Yin; Rauf Latif
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 3.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

4.  Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.

Authors:  T Majima; Y Komatsu; K Doi; C Takagi; M Shigemoto; A Fukao; T Morimoto; J Corners; K Nakao
Journal:  Osteoporos Int       Date:  2006-04-07       Impact factor: 4.507

5.  Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells.

Authors:  G Ramajayam; R C Vignesh; S Karthikeyan; K Senthil Kumar; G D Karthikeyan; S Veni; M Sridhar; J Arunakaran; M Michael Aruldhas; N Srinivasan
Journal:  Mol Cell Biochem       Date:  2012-06-07       Impact factor: 3.396

6.  Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells.

Authors:  Tomoyuki Aoki; Katsuhiko Tsunekawa; Osamu Araki; Takayuki Ogiwara; Makoto Nara; Hiroyuki Sumino; Takao Kimura; Masami Murakami
Journal:  Endocrinology       Date:  2015-08-18       Impact factor: 4.736

7.  Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?

Authors:  Tina Z Belsing; Charlotte Tofteng; Bente L Langdahl; Peder Charles; Ulla Feldt-Rasmussen
Journal:  Nutr Metab (Lond)       Date:  2010-09-01       Impact factor: 4.169

8.  Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.

Authors:  Erika L Souza Meyer; Iuri M Goemann; José Miguel Dora; Marcia S Wagner; Ana Luiza Maia
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

9.  Iodothyronine deiodinase enzyme activities in bone.

Authors:  Allan J Williams; Helen Robson; Monique H A Kester; Johannes P T M van Leeuwen; Stephen M Shalet; Theo J Visser; Graham R Williams
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

10.  The Glu727 Allele of Thyroid Stimulating Hormone Receptor Gene is Associated with Osteoporosis.

Authors:  Ren-De Liu; Rui-Xiong Chen; Wen-Rui Li; Yu-Liang Huang; Wen-Hu Li; Guang-Rong Cai; Heng Zhang
Journal:  N Am J Med Sci       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.